Secondary prophylaxis for variceal bleeding: carvedilol vs. propranolol Christian J. SteibAlexander L. Gerbes Editorial 23 February 2017 Pages: 141 - 142
Existence of cancer stem cells in hepatocellular carcinoma: myth or reality? Keigo Machida Point of View 18 December 2016 Pages: 143 - 147
Living donor liver transplant (LDLT) is the way forward in Asia Mohamed RelaMettu Srinivas Reddy Point of View 17 January 2017 Pages: 148 - 151
Elbasvir/grazoprevir for treatment of chronic hepatitis C virus infection Chandana PapudesuShyamasundaran KottililShashwatee Bagchi Review Article 13 September 2016 Pages: 152 - 160
Sofosbuvir/velpatasvir: a pangenotypic drug to simplify HCV therapy Rebecca LeeShyam KottililEleanor Wilson Review Article 07 December 2016 Pages: 161 - 170
Virus-induced hepatocellular carcinoma with special emphasis on HBV Ming WangDong XiQin Ning Review Article 17 January 2017 Pages: 171 - 180
Carvedilol versus propranolol effect on hepatic venous pressure gradient at 1 month in patients with index variceal bleed: RCT Vipin GuptaRamakant RawatAnoop Saraya Original Article 13 September 2016 Pages: 181 - 187
Efficacy and safety of daclatasvir plus pegylated-interferon alfa 2a and ribavirin in previously untreated HCV subjects coinfected with HIV and HCV genotype-1: a Phase III, open-label study Mark S. SulkowskiWalford J. FesselPeter Ackerman Original Article 16 February 2017 Pages: 188 - 198
HATT: a phase IV, single-arm, open-label study of sorafenib in Taiwanese patients with advanced hepatocellular carcinoma Shi-Ming LinSheng-Nan LuGerold Meinhardt Original Article Open access 01 December 2016 Pages: 199 - 208
Clinical validity of Metroticket calculator in transplant patients undergoing prior chemoembolization for hepatocellular carcinoma Hyung-Don KimGi-Won SongSung-Gyu Lee Original Article 31 January 2017 Pages: 209 - 219